10-Q Filing

PRIVIA HEALTH GROUP, INC. CIK: 1759655 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001759655-21-000023`
Period End Date	20210630
Filing Date	20210809
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	prva-20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 77 Income Statement 74 Cash Flow Statement 66 Stockholders Equity 24

Balance Sheet 77 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$84.63M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	105.74M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$299.75M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	95.99M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	95.99M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	105.74M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$99.12M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$126.87M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.33M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$9.83M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$436.45M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$190.08M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.81M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.45M	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.62M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$5.98M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$5.66M	USD	Point-in-time
Goodwill	`Goodwill`	$118.66M	USD	Point-in-time
Goodwill	`Goodwill`	$118.66M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$23.16M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$4.95M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.47M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.14M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$138.88M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$160.69M	USD	Point-in-time
Total assets	`Assets`	$328.97M	USD	Point-in-time
Total assets	`Assets`	$597.14M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.24M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.52M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$31.18M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$23.91M	USD	Point-in-time
Physician and practice liability	`PhysicianAndPracticeLiabilityCurrent`	$106.81M	USD	Point-in-time
Physician and practice liability	`PhysicianAndPracticeLiabilityCurrent`	$131.03M	USD	Point-in-time
Current portion of note payable	`NotesPayableCurrent`	$1.31M	USD	Point-in-time
Current portion of note payable	`NotesPayableCurrent`	$875.00K	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$2.19M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$4.36M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$2.83M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$146.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$167.32M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$32.78M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$31.89M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$8.12M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$333.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$5.59M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$38.38M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$40.35M	USD	Point-in-time
Total Liabilities	`Liabilities`	$207.67M	USD	Point-in-time
Total Liabilities	`Liabilities`	$185.32M	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value, 1,000,000,000 and 150,000,000 shares authorized; 105,740,462 and 95,985,817 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$960.00K	USD	Point-in-time
Common stock, $0.01 par value, 1,000,000,000 and 150,000,000 shares authorized; 105,740,462 and 95,985,817 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$1.06M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$165.67M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$579.26M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-19.88M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-187.01M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$393.30M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$146.75M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-3.83M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-3.10M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$389.47M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$107.46M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$149.37M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$112.91M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$118.22M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$597.14M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$328.97M	USD	Point-in-time

Income Statement 74 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$183.26M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$225.76M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$396.21M	USD	2 Qtrs
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$439.36M	USD	2 Qtrs
Physician and practice expense	`PhysicianAndPracticeExpense`	$169.94M	USD	1 Quarter
Physician and practice expense	`PhysicianAndPracticeExpense`	$331.05M	USD	2 Qtrs
Physician and practice expense	`PhysicianAndPracticeExpense`	$306.63M	USD	2 Qtrs
Physician and practice expense	`PhysicianAndPracticeExpense`	$141.52M	USD	1 Quarter
Cost of platform	`CostOfPlatform`	$24.33M	USD	1 Quarter
Cost of platform	`CostOfPlatform`	$68.73M	USD	1 Quarter
Cost of platform	`CostOfPlatform`	$51.89M	USD	2 Qtrs
Cost of platform	`CostOfPlatform`	$95.69M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$4.67M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$2.22M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$14.36M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$11.18M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$19.41M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$182.65M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$8.42M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$168.66M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$932.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$440.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$885.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$594.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$418.94M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$383.53M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$177.09M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$624.64M	USD	2 Qtrs
Operating (loss) income	`OperatingIncomeLoss`	$6.18M	USD	1 Quarter
Operating (loss) income	`OperatingIncomeLoss`	$-185.28M	USD	2 Qtrs
Operating (loss) income	`OperatingIncomeLoss`	$-193.19M	USD	1 Quarter
Operating (loss) income	`OperatingIncomeLoss`	$12.68M	USD	2 Qtrs
Interest expense	`InterestIncomeExpenseNet`	$-509.00K	USD	1 Quarter
Interest expense	`InterestIncomeExpenseNet`	$-976.00K	USD	2 Qtrs
Interest expense	`InterestIncomeExpenseNet`	$-593.00K	USD	2 Qtrs
Interest expense	`InterestIncomeExpenseNet`	$-302.00K	USD	1 Quarter
(Loss) income before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-193.49M	USD	1 Quarter
(Loss) income before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-185.87M	USD	2 Qtrs
(Loss) income before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.67M	USD	1 Quarter
(Loss) income before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$11.70M	USD	2 Qtrs
(Benefit from) Provision for income taxes	`IncomeTaxExpenseBenefit`	$474.00K	USD	1 Quarter
(Benefit from) Provision for income taxes	`IncomeTaxExpenseBenefit`	$-20.00M	USD	1 Quarter
(Benefit from) Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.17M	USD	2 Qtrs
(Benefit from) Provision for income taxes	`IncomeTaxExpenseBenefit`	$-18.00M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$5.62M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$10.53M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$-173.49M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.20M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.33M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-167.87M	USD	2 Qtrs
Less: Loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-170.00K	USD	2 Qtrs
Less: Loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-951.00K	USD	1 Quarter
Less: Loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-733.00K	USD	2 Qtrs
Less: Loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-85.00K	USD	1 Quarter
Net (loss) income attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-167.14M	USD	2 Qtrs
Net (loss) income attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-172.53M	USD	1 Quarter
Net (loss) income attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$10.70M	USD	2 Qtrs
Net (loss) income attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$5.28M	USD	1 Quarter
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-1.68	USD	1 Quarter
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$0.06	USD	1 Quarter
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$0.11	USD	2 Qtrs
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-1.68	USD	2 Qtrs
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.11	USD	2 Qtrs
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.68	USD	2 Qtrs
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.06	USD	1 Quarter
Net (loss) income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.68	USD	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	95.93M	shares	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	95.93M	shares	2 Qtrs
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	99.38M	shares	2 Qtrs
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	102.74M	shares	1 Quarter
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	99.38M	shares	2 Qtrs
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	102.74M	shares	1 Quarter
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.93M	shares	1 Quarter
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.93M	shares	2 Qtrs

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`ProfitLoss`	$5.62M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$10.53M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$-173.49M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.20M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.33M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-167.87M	USD	2 Qtrs
Depreciation	`Depreciation`	$599.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$564.00K	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$321.00K	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$200.00K	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$200.00K	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$320.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$67.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$77.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$202.66M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$242.00K	USD	2 Qtrs
Deferred tax (benefit) provision	`DeferredIncomeTaxExpenseBenefit`	$-18.21M	USD	2 Qtrs
Deferred tax (benefit) provision	`DeferredIncomeTaxExpenseBenefit`	$1.27M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$20.65M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$27.75M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.54M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$9.11M	USD	2 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-1.34M	USD	2 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-2.30M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.36M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-810.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-7.28M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-3.94M	USD	2 Qtrs
Physician and practice liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$14.01M	USD	2 Qtrs
Physician and practice liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$24.22M	USD	2 Qtrs
Other current liabilities	`IncreaseDecreaseInOtherCurrentLiabilities`	$617.00K	USD	2 Qtrs
Other current liabilities	`IncreaseDecreaseInOtherCurrentLiabilities`	$1.53M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$10.31M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	-	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$512.00K	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-5.26M	USD	2 Qtrs
Net cash provided by in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.73M	USD	2 Qtrs
Net cash provided by in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$6.69M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$379.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$199.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-199.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-379.00K	USD	2 Qtrs
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	2 Qtrs
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	$223.69M	USD	2 Qtrs
Payments of underwriting fees, net of discounts and offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	2 Qtrs
Payments of underwriting fees, net of discounts and offering costs	`PaymentsOfStockIssuanceCosts`	$12.66M	USD	2 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	$438.00K	USD	2 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	$438.00K	USD	2 Qtrs
Proceeds from revolving loan	`ProceedsFromLinesOfCredit`	$10.00M	USD	2 Qtrs
Proceeds from revolving loan	`ProceedsFromLinesOfCredit`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.56M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$210.59M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$215.12M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$15.87M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$62.76M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.63M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.89M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$299.75M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$62.76M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.63M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$46.89M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$299.75M	USD	Point-in-time
Interest paid	`InterestPaidNet`	$914.00K	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$585.00K	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$451.00K	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$46.00K	USD	2 Qtrs

Stockholders Equity 24 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$389.47M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$107.46M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$149.37M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$112.91M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$118.22M	USD	Point-in-time
Issuance of common stock upon closing of initial public offering	`StockIssuedDuringPeriodValueNewIssues`	$210.99M	USD	1 Quarter
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueShareBasedCompensation`	$33.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$121.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$101.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$121.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$202.56M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.62M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$10.53M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$-173.49M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.20M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.33M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-167.87M	USD	2 Qtrs
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$389.47M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$107.46M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$149.37M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$112.91M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$118.22M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.